Refine
Year of publication
Document Type
- Article (12)
- Working Paper (1)
Has Fulltext
- yes (13)
Is part of the Bibliography
- no (13)
Keywords
- multiple sclerosis (2)
- sound-induced flash illusion (2)
- Advanced biliary tract cancer (1)
- BTC (1)
- Bindungsproblem (1)
- Crossmodal (1)
- EEG (1)
- Evaluation (1)
- Functional connectivity (1)
- Functional magnetic resonance imaging (1)
- Hand-foot syndrome (1)
- Hif1α (1)
- Independent component analysis (1)
- Medizinische Psychologie (1)
- Multisensory (1)
- Object perception (1)
- Objekterkennung (1)
- PDGFRβ (1)
- Praktikum (1)
- Psychophysiologie (1)
- Sorafenib (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- aging (1)
- beta-band activity (1)
- c-kit (1)
- cognition (1)
- cognitive deficits (1)
- cognitive impairment (CI) (1)
- congruency (1)
- connectional fingerprint (1)
- cortex (1)
- cross-modal (1)
- diffusion tensor imaging (1)
- dynamic causal modeling (1)
- evaluation (1)
- everyday tasks (1)
- eye tracking (ET) (1)
- fMRT (1)
- functional magnetic resonance imaging (1)
- funktionelle Hirnbildgebung (1)
- graph theory (1)
- human (1)
- magnetoencephalography (1)
- medical psychologoy (1)
- multisensorische Integration (1)
- multisensory (1)
- multisensory integration (1)
- neuroinformatics (1)
- neuropsychological impairment (1)
- object perception (1)
- practical exercises (1)
- predictive coding (1)
- psychophysiology (1)
- schizophrenia (1)
- screening test (1)
- transfer entropy (1)
- visual search (VS) (1)
Institute
- Medizin (11)
- Psychologie (6)
- MPI für Hirnforschung (3)
- Frankfurt Institute for Advanced Studies (FIAS) (2)
- Center for Financial Studies (CFS) (1)
- House of Finance (HoF) (1)
- MPI für empirische Ästhetik (1)
- Psychologie und Sportwissenschaften (1)
- Sustainable Architecture for Finance in Europe (SAFE) (1)
- Wirtschaftswissenschaften (1)
Background: Since sorafenib has shown activity in different tumour types and gemcitabine regimens improved the outcome for biliary tract cancer (BTC) patients, we evaluated first-line gemcitabine plus sorafenib in a double-blind phase II study.
Patients and methods: 102 unresectable or metastatic BTC patients with histologically proven adenocarcinoma of gallbladder or intrahepatic bile ducts, Eastern Cooperative Oncology Group (ECOG) 0–2 were randomised to gemcitabine (1000 mg/m2 once weekly, first 7-weeks + 1-week rest followed by once 3-weeks + 1-week rest) plus sorafenib (400 mg twice daily) or placebo. Treatment continued until progression or unacceptable toxicity. Tumour samples were prospectively stained for sorafenib targets and potential biomarkers. Serum samples (first two cycles) were measured for vascular endothelial growth factors (VEGFs), vascular endothelial growth factor receptor 2 (VEGFR-2) and stromal cell-derived factor 1 (SDF1)α by enzyme-linked immunosorbent assay (ELISA).
Results: Gemcitabine plus sorafenib was generally well tolerated. Four and three patients achieved partial responses in the sorafenib and placebo groups, respectively. There was no difference in the primary end-point, median progression-free survival (PFS) for gemcitabine plus sorafenib versus gemcitabine plus placebo (3.0 versus 4.9 months, P = 0.859), and no difference for median overall survival (OS) (8.4 versus 11.2 months, P = 0.775). Patients with liver metastasis after resection of primary BTC survived longer with sorafenib (P = 0.019) compared to placebo. Patients who developed hand-foot syndrome (HFS) showed longer PFS and OS than patients without HFS. Two sorafenib targets, VEGFR-2 and c-kit, were not expressed in BTC samples. VEGFR-3 and Hif1α were associated with lymph node metastases and T stage. Absence of PDGFRβ expression correlated with longer PFS.
Conclusion: The addition of sorafenib to gemcitabine did not demonstrate improved efficacy in advanced BTC patients. Biomarker subgroup analysis suggested that some patients might benefit from combined treatment.
Non-standard errors
(2021)
In statistics, samples are drawn from a population in a data-generating process (DGP). Standard errors measure the uncertainty in sample estimates of population parameters. In science, evidence is generated to test hypotheses in an evidence-generating process (EGP). We claim that EGP variation across researchers adds uncertainty: non-standard errors. To study them, we let 164 teams test six hypotheses on the same sample. We find that non-standard errors are sizeable, on par with standard errors. Their size (i) co-varies only weakly with team merits, reproducibility, or peer rating, (ii) declines significantly after peer-feedback, and (iii) is underestimated by participants.
Multisensory integration strongly depends on the temporal proximity between two inputs. In the audio-visual domain, stimulus pairs with delays up to a few hundred milliseconds can be perceived as simultaneous and integrated into a unified percept. Previous research has shown that the size of this temporal window of integration can be narrowed by feedback-guided training on an audio-visual simultaneity judgment task. Yet, it has remained uncertain how the neural network that processes audio-visual asynchronies is affected by the training. In the present study, participants were trained on a 2-interval forced choice audio-visual simultaneity judgment task. We recorded their neural activity with magnetoencephalography in response to three different stimulus onset asynchronies (0 ms, each participant’s individual binding window, 300 ms) before, and one day following training. The Individual Window stimulus onset asynchrony condition was derived by assessing each participant’s point of subjective simultaneity. Training improved performance in both asynchronous stimulus onset conditions (300 ms, Individual Window). Furthermore, beta-band amplitude (12–30 Hz) increased from pre-compared to post-training sessions. This increase moved across central, parietal, and temporal sensors during the time window of 80–410 ms post-stimulus onset. Considering the putative role of beta oscillations in carrying feedback from higher to lower cortical areas, these findings suggest that enhanced top-down modulation of sensory processing is responsible for the improved temporal acuity after training. As beta oscillations can be assumed to also preferentially support neural communication over longer conduction delays, the widespread topography of our effect could indicate that training modulates not only processing within primary sensory cortex, but rather the communication within a large-scale network.